MedPacto (235980) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩116M ($80K) in reported transaction value. The earliest filing StockDrifts holds for MedPacto is dated 2025-03-05; the most recent is 2025-03-06. Across these filings the average return since disclosure is +60.11%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | BUY | PROGRAM | 우정원 Woojeongwon | president | 15.0K | ₩3,635 | +60.1% | ₩55M ($38K) |
| 2025-03-06 | BUY | PROGRAM | 김성진 Seongjin Kim | CEO | 31.9K | ₩3,635 | +60.1% | ₩116M ($80K) |
| 2025-03-06 | BUY | PROGRAM | 이지훈 Jihoon Lee | Managing Director | 7.0K | ₩3,635 | +60.1% | ₩25M ($18K) |
| 2025-03-05 | BUY | PROGRAM | 양경민 Kyungmin Yang | Managing Director | 10.0K | ₩3,405 | +70.9% | ₩34M ($24K) |
| 2025-03-05 | BUY | PROGRAM | 장민후 Jang Min-hoo | Managing Director | 10.5K | ₩3,405 | +70.9% | ₩36M ($25K) |
| 2025-03-05 | BUY | PROGRAM | 허민규 Heo Min-gyu | Managing Director | 10.0K | ₩3,405 | +70.9% | ₩34M ($24K) |
| 2025-03-05 | BUY | PROGRAM | 우정원 Woojeongwon | president | 15.0K | ₩3,405 | +70.9% | ₩51M ($35K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.